Abstract
Hepatitis B (HBV) and C (HCV) viruses are well-recognized causes for chronic hepatitis, cirrhosis, and even for hepatocellular carcinoma. Apart from liver disease, these viral infections are known to be associated with a spectrum of extrahepatic manifestations. The prevalence of clinically significant extrahepatic manifestations is relatively low, but it can be associated with significant morbidity and even mortality. An awareness and recognition of these manifestations is of paramount importance in facilitating early diagnosis and in offering treatment. However, treatments are not necessarily effective, and patients may continue with disabling extrahepatic manifestations. Hepatitis B virus has been well recognized as causing a variety of manifestations that include skin rash, arthritis, arthralgia, glomerulonephritis, polyarteritis nodosa, and papular acrodermatitis. More recently, infection with hepatitis C virus has elicited considerable interest for its role in a spectrum of extrahepatic manifestations. Among the best-reported are cryoglobulinemia, glomerulonephritis, high titer of autoantibodies, idiopathic thrombocytopenic purpura, lichen planus, Mooren’s corneal ulcer, Sjögren’s syndrome, porphyria cutanea tarda, and necrotizing cutaneous vasculitis. The precise pathogenesis of these extrahepatic complications has not been determined, although the majority represent the clinical expression of autoimmune phenomena.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Laskus T, Radkowski M, Wang LF, et al.: Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative strand viral RNA in various tissues. Hepatology 1998, 28:1398–1404.
Caputo R, Gelmetti C, Ermacora E, et al.: Gianotti-Crosti syndrome: a retrospective analysis of 308 cases. J Am Acad Dermatol 1992, 26:207–210.
Clark E, Kaplan BI: Endocardial, arterial, and other mesenchymal alterations associated with serum sickness in man. Arch Pathol 1937, 24:458.
Trepo CH, Thivolet J: Australia antigen,virus hepatitis and periarteritis nodosa. Presse Med 1970, 78:1575.
Cacoub P, Lunel Fabiani F, Du LTH: Polyarteritis nodosa and hepatitis C virus infection. Ann Intern Med 1992, 16:605–606.
Guillevin L, Lhote F, Gayraud M, et al.: Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. Medicine 1996, 75:17–28.
Guillevin L, Lhote F, Cohen, et al.: Polyarteritis nodosa related to hepatitis B virus: a prospective study of 41 patients. Medicine 1995, 74:238–253.
Guillevin L, Lhote F, Sauvaget F, et al.: Treatment of polyarteritis nodosa related to hepatitis B virus with interferon alpha and plasma exchange. Ann Rheum Disease 1994, 53:334–337.
Lam KC, Lai CL, Trepo CH, et al.: Deleterious effect of prednisolone in HbsAg-positive chronic active hepatitis. N Engl J Med 1981, 304:380–386.
Pinto PC, Hu E, Bernestein-Singer M, et al.: Acute hepatic injury after withdrawal of immunosuppressive chemotherapy in patients with hepatitis B. Cancer 1990, 65:878–884.
Combes B, Shorey J, Baarrera A, et al.: Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 1971, 2:234.
Takekoshi Y, Tanaka M, Shida N, et al.: Strong association between membranous nephropathy and hepatitis-B surface antigenaemia in Japanese children. Lancet 1978, 18:1065–1068.
Brzosko WJ, Drawczynski R, Nazarewicz T, et al.: Glomerulonephritis associated with hepatitis-B surface antigen immune complexes in children. Lancet 1974, 2:477.
Lai KN, Lai FM, Chan KW, et al.: The clinico-pathologic features of hepatitis B associated glomerulonephritis. QJM 1987, 63:323–333.
Lai FM, Lai KN, Tam JS, et al.: Primary glomerulonephritis with detectable glomerular hepatitis B virus antigens. Am J Surg Pathol 1994, 18:175–186.
Ito H, Hattori S, Matsuda I, et al.: Hepatitis Be antigenmediated membranous glomerulonephritis. Lab Invest 1981, 44:214.
Takekoshi Y, Tanaka M, Miyakawa Y, et al.: Free ’small’ and IgG-associated ’large’ hepatitis B antigen in the serum and glomerular capillary walls of two patients with membranous glomerulonephritis. N Engl J Med 1979 12, 300:814–819.
He XY, Fang LJ, Zhang YE, et al.: In situ hybridization of hepatitis B DNA in hepatitis B-associated glomerulonephritis. Pediatr Nephrol 1998, 12:117–120.
Conjeevaram HS, Hoofnagle JH, Austin HA, et al.: Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology 1995, 109:540–546. An important paper concerning the natural history of glomerulonephritis after treatment with IFN-a.
Chung DR, Yang WS, Kim SB, et al.: Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon. Am J Nephrol 1997, 17:112–117. Observations on response to treatment in patients with chronic HBV infection and glomerulonephritis.
Quan A, Portale A, Foster S, Lavine J: Resolution of hepatitis B virus related membranoproliferative glomerulonephritis after orthotopic liver transplantation. Pediatr Nephrol 1995, 9:599–602.
McMahon BJ, Alberts SR, Wainwright RB, et al.: Hepatitis B-related sequelae: prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med 1990, 150:1051–1054.
Lai KN, Li PK, Lui SF, et al.: Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991, 324:1457–1463.
Lohr H, Goergen B, Weber W, et al.: Mixed cryoglobulinemia type II in chronic hepatitis B associated with HBe-minus HBV mutant: cellular immune reactions and response to interferon treatment. J Med Virol 1994, 44:330–335.
McMurray R: Hepatitis C associated autoimmune disorders. Rheum Dis Clin North Am 1998, 24:353–374. Extensive review of various autoimmune manifestations in patients with chronic HCV infection.
Pawlotsky JM, Ben Yahia M, Andre C, et al.: Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994, 19:841–848.
Czaja AJ: Extrahepatic immunologic features of chronic viral hepatitis. Dig Dis Sci 1997, 15:125–144. Excellent review of various autoimmune phenomena in patients with chronic HCV infection.
Mergener K, Michel G, Braun HB, et al.: Anti-GOR titers in chronic hepatitis C in relation to interferon therapy. J Hepatol 1992, 16:4A.
Casato M, Taliani G, Pucilo, et al.: Cryoglobulinemia and hepatitis C virus. Lancet 1991, 337:1047–1048.
Durand JM, Lefevre H: Cutaneous vasculitis and cryoglobulinemia type II associated with hepatitis C virus infection. Lancet 1991, 337:499–500.
Dammacco F, Zorzoli I, Cerino A, et al.: Clonality and specificity of cryoglobulins associated with HCV: pathophysiological implications. J Hepatology 1998, 29:879–886.
VanThielD, Fagiouoli S, Caraceni P, et al.: Cryoglobulinemia: a cause for negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease. J Hepatol 1995, 22:446–467.
Zignego AL, Ferri C, Giannini, et al.: Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996, 124:31–34.
Lenzi M, Frisoni M, Mantovani V, et al.: Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia. Blood 1998, 91:2062–2066.
Misiani R, Bellavita P, Fenili D, et al.: Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994 17, 330:751–756.
D’Amico GD, Colasanti G, Ferrario F, et al.: Renal involvement in essential mixed cryoglobulinemia. Kidney Int 1989, 35:1004–1014.
Pham HP, Feray C, Samuel D, et al.: Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients. Kidney Int 1998, 54:1311–1319.
Johnson RJ, Gretch DR, Couser WG, et al.: Hepatitis C virusassociated glomerulonephritis: effect of alpha-interferon therapy. Kidney Int 1994, 46:1700–1704.
Okada K, Takishita Y, Shimomura H, et al.: Detection of hepatitis C virus core protein in the glomeruli of patients with membranous glomerulonephritis. Clin Nephrol 1996, 45:71–76.
Stehman-Breen C, Alpers CE, Couser WG, et al.: Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol 1995, 44:141–147.
Pakula AS, Garden JM, Roth SI: Cryoglobulinemia and cutaneous leukocytoclastic vasculitis associated with hepatitis C virus infection. J Am Acad Dermatol 1993, 28:850–853.
Rebora A, Patri P, Rampini E, et al.: Erosive lichen planus and cirrhotic hepatitis. Ital Gen Rev Dermatol 1978, 15:123–131.
Mokni M, Rybojad M, Puppin D Jr, et al.: Lichen planus and hepatitis C virus. J Am Acad Dematol 1991, 24:792.
Roy KM, Bagg J: Hepatitis C and oral disease: a critical review. Oral Dis 1999, 5:270–277. Good review of the various extrahepatic manifestations in patients with chronic HCV that can be found in the oral cavity.
Navas S, Bosch O, Castillo I, et al.: Porphyria cutanea tarda and hepatitis C and B viruses infection: a retrospective study. Hepatology 1995, 21:279–284.
Carson CW, Conn DL, Czaja AJ, et al.: Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993, 20:304–309.
Wilson SE, Lee WM, Murakami C, et al.: Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology 1994, 101:736–745.
Zignego AL, Ferri C, Giannini C, et al.: Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin’s lymphoma: evidence for a pathogenetic role. Arch Virol 1997, 142:545–555.
Mazzaro GS, Franzin F, Tulissi P, et al.: Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to interferon therapy. Cancer 1996, 77:2613. Important observations on the prevention of lymphomas in patients with chronic HCV.
Pawlotsky JM, Yahia MB, Andre C, et al.: Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994, 19:841–848.
Roti E, Minelli, Giuberti T, et al.: Multiple changes in thyroid function in patients with active HCV hepatitis treated with recombinant interferon-alpha. Am J Med 1996, 101:611–615.
Mason AL, Lau JY, Hoang N, et al.: Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999, 29:328–333. Controversial but significant report on the association of HCV with diabetes mellitus.
Caniatti LM, Tugnoli V, Eleopra R, et al.: Cryoglobulinemic neuropathy related to hepatitis C virus infection: clinical, laboratory and neurophysiological study. J Periph Nerv Syst 1996, 1:131–138.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pyrsopoulos, N.T., Reddy, K.R. Extrahepatic manifestations of chronic viral hepatitis. Curr Gastroenterol Rep 3, 71–78 (2001). https://doi.org/10.1007/s11894-001-0044-1
Issue Date:
DOI: https://doi.org/10.1007/s11894-001-0044-1